Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Semaglutide
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Ozempic 1mg/0.74ml inj 3ml pre-filled pens
0601023AWBBACAC
|
Ozempic | Semaglutide | Endocrine System | 86,516 |
|
Rybelsus 7mg tablets
0601023AWBCACAF
|
Rybelsus | Semaglutide | Endocrine System | 58,626 |
|
Rybelsus 14mg tablets
0601023AWBCAAAD
|
Rybelsus | Semaglutide | Endocrine System | 48,362 |
|
Semaglutide 1mg/0.74ml inj 3ml pre-filled disposable devices
0601023AWAAACAC
|
Semaglutide | Semaglutide | Endocrine System | 30,170 |
|
Semaglutide 7mg tablets
0601023AWAAAFAF
|
Semaglutide | Semaglutide | Endocrine System | 29,301 |
|
Rybelsus 3mg tablets
0601023AWBCABAE
|
Rybelsus | Semaglutide | Endocrine System | 27,709 |
|
Ozempic 0.5mg/0.37ml inj 1.5ml pre-filled pens
0601023AWBBABAB
|
Ozempic | Semaglutide | Endocrine System | 25,270 |
|
Semaglutide 14mg tablets
0601023AWAAADAD
|
Semaglutide | Semaglutide | Endocrine System | 23,255 |
|
Semaglutide 3mg tablets
0601023AWAAAEAE
|
Semaglutide | Semaglutide | Endocrine System | 15,613 |
|
Ozempic 0.25mg/0.19ml inj 1.5ml pre-filled pens
0601023AWBBAAAA
|
Ozempic | Semaglutide | Endocrine System | 14,445 |
|
Semaglutide 0.5mg/0.37ml inj 1.5ml pf dispos dev
0601023AWAAABAB
|
Semaglutide | Semaglutide | Endocrine System | 12,416 |
|
Semaglutide 0.25mg/0.19ml inj 1.5ml pf dispos dev
0601023AWAAAAAA
|
Semaglutide | Semaglutide | Endocrine System | 6,108 |
|
Semaglutide 1mg/0.75ml inj 3ml pre-filled disposable devices
0601023AWAAAIAI
|
Semaglutide | Semaglutide | Endocrine System | 704 |
|
Wegovy FlexTouch 1mg/0.75ml inj 3ml pre-filled pens
0601023AWBDADAI
|
Wegovy | Semaglutide | Endocrine System | 430 |
|
Wegovy FlexTouch 0.5mg/0.37ml inj 1.5ml pre-filled pens
0601023AWBDAAAB
|
Wegovy | Semaglutide | Endocrine System | 420 |
|
Semaglutide 1.7mg/0.75ml inj 3ml pf dispos dev
0601023AWAAAHAH
|
Semaglutide | Semaglutide | Endocrine System | 355 |
|
Wegovy FlexTouch 0.25mg/0.37ml inj 1.5ml pre-filled pens
0601023AWBDABAG
|
Wegovy | Semaglutide | Endocrine System | 316 |
|
Semaglutide 0.25mg/0.37ml inj 1.5ml pf dispos dev
0601023AWAAAGAG
|
Semaglutide | Semaglutide | Endocrine System | 307 |
|
Semaglutide 2.4mg/0.75ml inj 3ml pf dispos dev
0601023AWAAAJAJ
|
Semaglutide | Semaglutide | Endocrine System | 251 |
|
Wegovy FlexTouch 2.4mg/0.75ml inj 3ml pre-filled pens
0601023AWBDAEAJ
|
Wegovy | Semaglutide | Endocrine System | 227 |
|
Wegovy FlexTouch 1.7mg/0.75ml inj 3ml pre-filled pens
0601023AWBDACAH
|
Wegovy | Semaglutide | Endocrine System | 206 |
|
Rybelsus 1.5mg tablets
0601023AWBCADAK
|
Rybelsus | Semaglutide | Endocrine System | No data available |
|
Rybelsus 4mg tablets
0601023AWBCAEAL
|
Rybelsus | Semaglutide | Endocrine System | No data available |
|
Rybelsus 9mg tablets
0601023AWBCAFAM
|
Rybelsus | Semaglutide | Endocrine System | No data available |
|
Semaglutide 1.5mg tablets
0601023AWAAAKAK
|
Semaglutide | Semaglutide | Endocrine System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.